Literature DB >> 31157005

Individualised antimicrobial dosing in critically ill patients undergoing continuous renal replacement therapy: focus on total drug clearance.

Jesus Ruiz1, Cassandra Favieres2, Maria Jesús Broch3, Esther Villarreal1, Monica Gordon3, Adrián Quinzá3, Álvaro Castellanos Ortega3, Paula Ramirez3.   

Abstract

BACKGROUND: Continuous renal replacement therapy (CRRT) is common practice in critical care patients with acute renal failure.
OBJECTIVES: To evaluate the adequacy of antimicrobial doses calculated based on the total drug clearance and dose recommended by different guides in critically ill patients undergoing CRRT.
METHODS: Retrospective observational study. Patients admitted to a critical care unit during May 2014 to May 2016 and subjected to CRRT were included. The recommended dose was established as the product of the usual dose of the drug by total drug clearance.
RESULTS: 177 antimicrobial agents, used in 64 patients were analysed; 45 (25.4%) antimicrobials were given in an insufficient dose (<20%) according to the theoretical calculation. Following the recommendations in the revised guidelines, between 10% and 20% of antimicrobials were given in insufficient doses. A higher success rate of treatment in those patients not receiving a low drug dosage was seen (35.2% vs 24.0%).
CONCLUSIONS: There is a great disparity between the antimicrobial dose prescribed, recommended and calculated based on drug clearance in critically ill patients undergoing CRRT.

Entities:  

Keywords:  Infection; antibiotics; bacteremia; hemofiltration

Year:  2017        PMID: 31157005      PMCID: PMC6452407          DOI: 10.1136/ejhpharm-2016-001114

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  28 in total

Review 1.  Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.

Authors:  J F Bugge
Journal:  Acta Anaesthesiol Scand       Date:  2001-09       Impact factor: 2.105

Review 2.  Adjunctive therapies in sepsis: an evidence-based review.

Authors:  Alain Cariou; Christophe Vinsonneau; Jean-François Dhainaut
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

Review 3.  Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.

Authors:  Robin L Trotman; John C Williamson; D Matthew Shoemaker; William L Salzer
Journal:  Clin Infect Dis       Date:  2005-09-12       Impact factor: 9.079

4.  Using imipenem and cilastatin during continuous renal replacement therapy.

Authors:  Alison Cotton; Bryony Dean Franklin; Stephen Brett; Alison Holmes
Journal:  Pharm World Sci       Date:  2005-10

5.  Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.

Authors:  T F Ververs; A van Dijk; S A Vinks; P J Blankestijn; J F Savelkoul; J Meulenbelt; F T Boereboom
Journal:  Crit Care Med       Date:  2000-10       Impact factor: 7.598

6.  Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome.

Authors:  Eric A J Hoste; Norbert H Lameire; Raymond C Vanholder; Dominique D Benoit; Johan M A Decruyenaere; Francis A Colardyn
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

7.  Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.

Authors:  L J Giles; A C Jennings; A H Thomson; G Creed; R J Beale; A McLuckie
Journal:  Crit Care Med       Date:  2000-03       Impact factor: 7.598

8.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

9.  Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia.

Authors:  Malina Ioanas; Miquel Ferrer; Manuela Cavalcanti; Ricard Ferrer; Santiago Ewig; Xavier Filella; Jordi Puig de la Bellacasa; Antoni Torres
Journal:  Crit Care Med       Date:  2004-04       Impact factor: 7.598

10.  Higher renal replacement therapy dose delivery influences on drug therapy.

Authors:  Bruce A Mueller; Deborah A Pasko; Kevin M Sowinski
Journal:  Artif Organs       Date:  2003-09       Impact factor: 3.094

View more
  3 in total

1.  Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury.

Authors:  Laura Butragueño-Laiseca; Iñaki F Troconiz; Santiago Grau; Nuria Campillo; Xandra García; Belén Padilla; Sarah N Fernández; María José Santiago
Journal:  Antibiotics (Basel)       Date:  2020-12-10

2.  Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units.

Authors:  Elodie Matusik; Justine Lemtiri; Guillaume Wabont; Fabien Lambiotte
Journal:  BMC Nephrol       Date:  2022-01-29       Impact factor: 2.388

3.  Anti-infective Medicines Use in Children and Neonates With Pre-existing Kidney Dysfunction: A Systematic Review.

Authors:  Chiara Minotti; Elisa Barbieri; Denis Doni; Cristina Impieri; Carlo Giaquinto; Daniele Donà
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.